IR Library

2022/12/19

Company Research and Analysis Report from OMEGA Investment (updated version) [PDF：2109KB]

2022/12/09

Announcement of the record date for the convocation of extraordinary meeting of shareholders [PDF：84KB]

2022/12/07

Announcement of research results at the annual meeting of 66th Japan Society for Neonatal Health and Development -Therapeutic effects of SHED on chronic cerebral palsy model- [PDF：257KB]

2022/12/06

Announcement of request for convocation of extraordinary meeting of shareholders [PDF：145KB]

2022/12/05

Announcement of participation in the open innovation initiative “i2.JP (Innovation Infusion Japan)” led by AstraZeneca K.K. [PDF：236KB]

2022/11/28

Announcement of publication of the third research article in collaboration with Hamamatsu University School of Medicine 
[PDF：151KB]

2022/11/22

2022/11/17

Company note 2Q FY2023/3 update from OMEGA Investment [PDF：724KB]

2022/11/10

[Presentation] R＆D Meeting 2022  -Growth Strategies of Cell Therapy (Regenerative Medicine) Business- [PDF：1847KB]

2022/11/08

Summary of Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2023 (Excerpt from Japanese version)
[PDF：419KB]

2022/11/08

[Presentation] Financial Results for the Second Quarter of FY2022 [PDF：2102KB]

2022/11/07

Announcement of publication of the research articles in collaboration with Hamamatsu University School of Medicine  [PDF：207KB]

2022/10/24

Announcement of a patent application on cell therapy for cerebral palsy utilizing SHED with Tokai National Higher Education and Research System (Extracted from Japanese version)

 

[PDF：207KB]

2022/10/13

Joint Press Release: Showa Denko Materials and Kidswell Bio Enter into an Agreement for Process Development and Clinical Manufacturing of Cell Therapy Products  [PDF：249KB]

2022/09/27

Announcement of master services agreement with Showa Denko Materials Co., Ltd. for the development of manufacturing process for regenerative medicine products and manufacturing investigational new drugs (Extracted from Japanese version)

 

[PDF：127KB]

2022/08/31

Announcement of completion of SHED Master Cell Bank in compliance with GMP [PDF：212KB]

2022/08/31

[Presentation] SHED Master Cell Bank completed [PDF：2431KB]

2022/08/16

Company note 1Q FY2023/3 update from OMEGA Investment [PDF：826KB]

2022/08/05

[Presentation] Financial Results for the First Quarter of FY2022 [PDF：2431KB]

2022/08/05

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023 (Extracted from Japanese version) [PDF：468KB]

2022/06/23

Financial Measures for Increased Orders of GBS-007 [PDF：1589KB]

2022/05/26

[Presentation] Medium Term Strategic Plan -KWB2.0- (Full version) [PDF：3950KB]

2022/05/26

Announcement of research collaboration agreement with Chiome Bioscience Inc. for the development of antibody drugs (Extracted from Japanese version)

 

[PDF：91KB]

2022/05/20

Company Research and Analysis Report from OMEGA Investment [PDF：311KB]

2022/05/12

Company note 4Q update from OMEGA Investment [PDF：245KB]

2022/05/12

[Presentation] Financial Results for the FY 2021 [PDF：2994KB]

2022/05/12

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (Extracted from Japanese version) [PDF：721KB]

2022/05/12

Announcement of Appointment of Accounting Auditor [PDF：126KB]

2022/04/04

Announcement of execution of share transfer agreement of the consolidated subsidiary and share purchase agreement with Metcela Inc., and change in the purpose of the 10th share acquisition rights due to this transaction (Extracted from Japanese version)

[PDF：291KB]

2022/03/24

2022/03/17

2022/03/07

Company note 3Q update from OMEGA Investment [PDF：523KB]

2022/02/04

[Presentation] Financial Results for the Third Quarter of FY2021 [PDF：1670KB]

2022/02/04

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022
[PDF：469KB]

2022/01/26

Announcement of business alliance agreement with Metcela Inc. for the regenerative medicine business [PDF：207KB]